Clinical Trials
2,407 trialsEarly-stage Detection of Liver Cancer by Proteins in Peripheral Blood
Second Affiliated Hospital, School of Medicine, Zhejiang University
REVIVE
Asan Medical Center
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
City of Hope Medical Center
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
M.D. Anderson Cancer Center
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
Northwestern University
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)
M.D. Anderson Cancer Center
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
TEP CARE
University Hospital, Lille
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
M.D. Anderson Cancer Center
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
CCGLC-011
Tongji Hospital
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
OHSU Knight Cancer Institute
FLEX-HCC
CHA University
HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)
Sun Yat-sen University
TERMOMIRNA
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
Icahn School of Medicine at Mount Sinai
Liver-NET1
University Hospital, Grenoble
SBS-CEUS
The First Hospital of Jilin University
A Comparative Study on the Diagnostic Efficacy of Ultrasound Contrast LI-RADS Grading and the German ESCULAP Standards for the Diagnosis of Recurrent Hepatic Mass Lesions After Hepatocellular Carcinoma Surgery
The First Hospital of Jilin University
TROG1703 LARK
University of Sydney
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
St. Jude Children's Research Hospital
Organoid Models of Hepatocellular Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mayo Clinic
Hepatocellular
The University of Hong Kong
RE-BALANCE
National Cancer Centre, Singapore
NYHCC
Peking Union Medical College Hospital
NARFI
University Hospital, Bordeaux
CIRT
Cardiovascular and Interventional Radiological Society of Europe
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Peking University First Hospital
Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging
First Affiliated Hospital, Sun Yat-Sen University
MARGIN
Northwestern University
PHITT
University of Birmingham
Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma
National Cancer Centre, Singapore
ELEGANCE
Nantes University Hospital
FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital
PLVT_TH
Assistance Publique - Hôpitaux de Paris
The DoHAICs Study Expansion Phase
Tianjin Medical University Cancer Institute and Hospital
AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)
Zhongda Hospital
Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma
Tongji Hospital
Standing Position Ultrasonography: Imaging Efficacy in Detecting Liver Diaphragmatic Dome Blind Area Lesions
The First Hospital of Jilin University
YMN-A02 for Advanced Primary Hepatocellular Carcinoma.
West China Hospital
HDL-CEUS-MRI
The First Hospital of Jilin University
Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular Carcinoma
University of Aberdeen
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Shanghai Zhongshan Hospital
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis
Zhongda Hospital
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions
Zhongda Hospital
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
Case Comprehensive Cancer Center
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Shandong Cancer Hospital and Institute
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
NRG Oncology
BILIFLEX
Fondazione Policlinico Universitario Agostino Gemelli IRCCS